New insights into the burden and costs of multiple sclerosis in Europe

The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis

(2016) Mervin Blair et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

A comparative analysis of Patient-Reported Expanded Disability Status Scale tools

(2016) Christian DE Collins et al.   Multiple Sclerosis Journal

A comparative analysis of Patient-Reported Expanded Disability Status Scale tools

(2016) Christian DE Collins et al.   Multiple Sclerosis Journal

Brain health: time matters in multiple sclerosis

(2016) Gavin Giovannoni et al.   Multiple Sclerosis and Related Disorders

A much-needed focus on progression in multiple sclerosis

(2015) Alan J Thompson   LANCET NEUROLOGY

Multiple sclerosis registries in Europe – results of a systematic survey

(2014) Peter Flachenecker et al.   Multiple Sclerosis Journal

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches

(2014) Shien Guo et al.   PHARMACOECONOMICS

Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis

(2013) Joel P. Thompson et al.   PHARMACOECONOMICS

The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach

(2013) Ingrid Lekander et al.   VALUE IN HEALTH

Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis

(2013) Annie Hawton et al.   Applied Health Economics and Health Policy

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

(2012) Peter Rieckmann et al.   JOURNAL OF NEUROLOGY

Self-assessment of Cognition in Multiple Sclerosis

(2011) Nadine Akbar et al.   Cognitive and Behavioral Neurology